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In the ﬁrst weeks of life young chickens are highly susceptible to infectious diseases due to immaturity of
the immune system. Little is known about the expression of host defense peptides (HDPs) during this
period. In this study we examined the expression pattern of two chicken HDPs, the cathelicidin CATH-2
and the b-defensin AvBD9 by immunohistochemistry in a set of organs from embryonic day 12 until four
weeks posthatch. AvBD9 was predominantly found in enteroendocrine cells throughout the intestine, the
ﬁrst report of in vivo HDP expression in this cell type, and showed stable expression levels during
development. CATH-2 was exclusively found in heterophils which decreased after hatch in most of the
examined organs including spleen, bursa and small intestine. In the lung CATH-2 expressionwas biphasic
and peaked at the ﬁrst day posthatch. In short, CATH-2 and AvBD9 appear to be expressed in cell types
strategically located to respond to infectious stimuli, suggesting these peptides play a role in embryonic
and early posthatch defense.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
During the neonatal period chickens are highly susceptible to
infectious diseases that cause relatively few problems later in the
life of the animals. Chickens younger than 2 weeks often develop
clinically apparent disease and severe symptoms when infected
with Escherichia coli or Salmonella (Gast and Beard, 1989; Goren,
1978; Johnson et al., 2001). This susceptibility is reﬂected in high
antibiotic usage in broilers during the ﬁrst week of life (GD Animal
Health, 2014). When chicks hatch, their immune system is imma-
ture and marked development occurs over the ﬁrst weeks of life.
During this period partial protection is offered by maternal anti-
bodies, transferred to chicks via the yolk. Most of these antibodies
are depleted by 10 days posthatch (Gharaibeh and Mahmoud,
2013). Though neonatal and even embryonic chicks are able to
mount humoral responses of their own, these are generally very
low. Antibody titers against orally or intramuscularly administered
BSA were higher in vaccinated animals older than 10 days
compared to animals vaccinated in the ﬁrst week posthatch (Bar-andijk1@uu.nl (A. van Dijk), r.
.P. Haagsman).
r Ltd. This is an open access articleShira et al., 2003; Mast and Goddeeris, 1999). Additionally, at
hatch the gut-associated lymphoid tissue is only poorly developed.
The numbers of lymphocytes in the intestinal wall are low at hatch,
but increase rapidly during the ﬁrst week (Bar-Shira et al., 2003).
Germinal centers in the cecal tonsils are not identiﬁed until two
weeks posthatch (Gomez Del Moral et al., 1998). Development of
the innate immune system in neonatal chicks is less well described,
though heterophils of 1 day old chicks show lower phagocytic and
bactericidal capacities compared to cells of animals of 4 and 7 days
old (Wells et al., 1998).
Host defense peptides (HDPs) are important multifunctional
effector molecules of the innate immune system. Two of the main
classes of HDPs are cathelicidins and defensins. In mammals, these
peptides are believed to be very important in neonatal defense
(Kai-Larsen et al., 2014). Expression of the human cathelicidin LL-37
and its murine counterpart CRAMP is higher in neonatal compared
to adult skin (Dorschner et al., 2003). In contrast, the expression of
intestinal a-defensins is lower in newborns, possibly predisposing
neonates to intestinal infections such as necrotizing enterocolitis
(Mallow et al., 1996). In the chicken, four cathelicidins and 14 b-
defensins have been described. Expression analysis of chicken
HDPs showed clear differences over the course of development.
Cathelicidin-1, -2 and -3 showed a strongly increased expression inunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Intestinal expression of the b-defensins 1, 2, 4 and 6 decreased in
the ﬁrst week posthatch, but increased again in the second week
(Bar-Shira and Friedman, 2006; Crhanova et al., 2011). However,
this researchwas solely based onmRNA levels and did not take into
account the cell types expressing these peptides and possible
changes herein during development.
In this work we aimed to elucidate the cellular localization and
developmental expression pattern of two chicken HDPs,
cathelicidin-2 (CATH-2) and b-defensin 9 (AvBD9, previously also
named GAL6) at the protein level, hereby increasing the knowledge
about the role of HDPs during chicken development.2. Materials and methods
2.1. Animals and tissue sampling
This animal experiment was conducted in accordance with a
protocol approved by the Dutch Animal Experimental Licensing
Committee (DEC). Twelve-day incubated Ross 308 broiler eggs
were obtained from a commercial hatchery (Lagerwey, Lunteren,
The Netherlands) and further incubated at the research facility of
the Department of Farm Animal Health (Utrecht University). After
hatch, chickens were housed in a ground stable under controlled
hygienic conditions. Chickens were fed a commercial broiler diet
without antibiotics or coccidostats and were given access to water
and food ad libitum. At multiple embryonic (ed12,14, 16, 18, 20) and
posthatch (d1, 4, 7, 14, 21, 28) timepoints, eggs/chickens (n ¼ 4/5)
were chosen at random for sample collection. Animals were
euthanized by cervical dislocation until posthatch day 7 and by
electrocution and bleeding at later timepoints.
Organs in contact with the external environment (intestine,
lung, skin) and a selection of lymphoid organs (spleen, bursa) were
chosen for analysis. Additional organs (yolk, pancreas, thymus,
kidney) were also sampled, but only perfunctory analysis on the
absence or presence of CATH-2 and AvBD9 expression was per-
formed for this study. During the experiment no symptoms of
disease were noticed in live birds or at post-mortem. Birds were
free of infectious bronchitis virus based on serology at d28.2.2. Antibodies
Rabbit polyclonal antibodies against CATH-2 and AvBD9 were
generated at Biogenes (Berlin, Germany). CATH-2 antibody pro-
duction was previously described (van Dijk et al., 2009a). For the
production of AvBD9 antibody, two short peptides derived from the
AvBD9 sequence (CSFVASRAPSVD and LASRQSHGSC) were conju-
gated to Limulus polyphemus hemocyanin (LPH) at the cysteine
residue and the mixture of peptides was used to immunize two
rabbits. Antiserum was collected from the immunized animals and
puriﬁed by afﬁnity chromatography on CNBr-Sepharose columns
coated with the peptides. Monospeciﬁc IgG was eluted from the
columns with 0.2 M Glycine-HCl buffer (250 mM NaCl, pH 2.2),
neutralized with 1 M Tris-HCl (pH 7.5) and centrifuged to remove
remaining debris. Antibodies were aliquoted and stored at 80 C.
For the staining of enteroendocrine cell (EEC) products, commercial
rabbit antibodies were used which had previously been shown to
work on chicken tissue samples: anti-glucagon-like peptide 1 (GLP-
1, GA1176, Enzo, Farmingdale, USA), anti-gastric inhibitory peptide
(GIP, T-4340, Peninsula Laboratories, San Carlos, USA) and anti-
serotonin (5-HT, 20080, Immunostar, Hudson, USA). Antibodies
were used in the following dilutions: 1:50 for anti-AvBD9,1:100 for
anti-CATH-2 and anti-5-HT, 1:200 for anti-GLP-1 and 1:500 for
anti-GIP.2.3. Tissue processing and sectioning
Tissue samples were ﬁxed in 4% paraformaldehyde (w/v) in
phosphate buffer (pH 7.2) for 24 h and subsequently parafﬁn-
embedded. Sections (5 mm for single or sequential staining or
2 mm for serial sections) were mounted on glass slides, deparafﬁ-
nized and rehydrated.
2.4. Immunohistochemistry
For antigen retrieval, sections were boiled in citrate buffer (pH
6.0) for 10 min (AvBD9, GLP-1 and GIP staining). Endogenous
peroxidase activity was blocked by incubating the sections for
30 min in 1% H2O2 in methanol. Subsequently, sections were
blocked with 10% normal goat serum and 2.5% BSA for 1 h before
incubation with the primary antibody (see section 2.2). Incubation
times of the primary antibodies were as follows: CATH-2, 1 h;
AvBD9, GLP-1, GIP and 5-HT overnight (16e20 h). Immunostaining
with rabbit serum or in absence of the primary antibody served as
the negative control. Sections for CATH-2 staining were then
incubated with the Horse Radish Peroxidase labelled anti-rabbit
polymer from the EnVision þ system (Dako, Glosstrup, Denmark).
All other sections were incubated with a biotinylated goat-anti-
rabbit antibody (1:250, Vector Laboratories, Burlingame, USA) for
30 min followed by incubation with ABC reagent (Vector Labora-
tories). Staining was visualized by incubating the sections with
diaminobenzidine (DAB) for 5e10 min. Finally, sections were
counterstained with hematoxylin, dehydrated and mounted with
Pertex.
2.5. Sequential stain with HE or Giemsa
Sections were sequentially stained with hematoxylin and eosin
(HE) followed by anti-AvBD9 or Giemsa followed by anti-CATH-2 to
elucidate morphology of AvBD9 and CATH-2 expressing cells.
Routine HE staining was performed in a Leica Autostainer XL (Son,
The Netherlands). For Giemsa stain, tissue sections were incubated
for 1 h in 20% Giemsa's Azure Eosin Methylene Blue solution
(Merck, Darmstadt, Germany) and differentiated in diluted acetic
acid for 15 min. Subsequently, differentiation was stopped by dip-
ping sections in ethanol 96% followed by incubation in aceton.
Photographs of distinctive cells were taken and subsequently sec-
tions were incubated overnight in fresh xylene to remove the cover
slips. Sections were then destained by incubation in acidiﬁed
ethanol (27 ml HCl 37% and 973 ml ethanol 70%) for 5 min. After
rehydration, sections were stained with antibodies against CATH-2
or AvBD9 as described above (section 2.4).
2.6. Silver staining
Fontana-Masson silver stain was performed on gastro-intestinal
tissue sections as previously described (Grimelius, 2004). Brieﬂy,
sections were incubated for 1 h in prewarmed ammoniacal silver
solution (5% AgNO3 with NH4OH) and rinsed in Milli-Q water.
Sections were counterstained with Nuclear Fast Red (Vector Labo-
ratories, Burlingame, USA), dehydrated and mounted with Vecta-
Mount (Vector Laboratories). Silver stained sections were
compared with serially cut sections stained with antibody against
AvBD9.
2.7. Quantitative analysis
Five to ten random photographs were made of each tissue sec-
tion using an Olympus BX51 microscope with movable table at
400x magniﬁcation (Field size 0.09 mm2). Images were analyzed
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obtain stained area percentages and stained cell numbers. ToFig. 1. Identiﬁcation of CATH-2 expressing cells as heterophils via sequential stain of secti
Arrows denote examples of CATH-2 expressing cells overlapping with cells identiﬁed as he
Fig. 2. Localization of CATH-2 expressing heterophils in the gastro-intestinal tract during d
serosa, lp: lamina propria, f: lymphoid follicle.account for the variation in empty space in the ﬁeld of view, a re-
gion including tissue only was manually created. Cell numbersons with CATH-2 antibody (A,C) and Giemsa (B,D). Lung (A,B) and bursa (C,D) at d28.
terophils.
evelopment. A: duodenum, ed18, B: duodenum, d28, C: cecum, d28, D: tonsil, d28. s:
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clustering of cells. The result of stained area percentage or stained
cell numbers for each tissue sample was calculated by taking the
average of the individual 5e10 image values.Fig. 3. Localization of CATH-2 expressing heterophils in multiple organs during developmen
ed18, H: d21).2.8. Statistics
Statistical analysis was performed using SPSS 22 software (IBM,
Armonk, USA). Differences between timepoints were evaluatedt. Bursa (A: ed18, B: d21), spleen (C: ed18, D: d21), lung (E: ed16, F: d21), and skin (G:
T. Cuperus et al. / Developmental and Comparative Immunology 61 (2016) 48e5952using a one-way analysis of variance (ANOVA) or non-parametric
Kruskal-Wallis test when data were non-normally distributed.
Differences were considered statistically signiﬁcant if p < 0.05.3. Results
3.1. Localization and identity of CATH-2 expressing cells and
developmental stage of heterophils
CATH-2 expressing cells were identiﬁed as heterophils based on
sequential stainingwith Giemsa (Examples of sequential staining in
bursa and lung shown in Fig. 1). All heterophils (mature and
developing) observed in this study expressed CATH-2. In all
analyzed tissues and in blood smears CATH-2 was never seen in
other cell types. CATH-2 expressing cells were observed from the
earliest timepoint (ed12) onwards in every organ investigated with
considerable variation in the numbers of CATH-2 expressing cells
between different organs.
In the gastro-intestinal tract, CATH-2 expressing heterophilsFig. 4. Overview of AvBD9 expressing cells in the gastro-intestinal tract. Expression was ﬁrs
later stages (B, ed18). AvBD9 expressing cells were seen in all parts of the intestine (jejunum
(E, ileum) and round or pyramidal in crypts (F, duodenum).were sparsely present as single cells in the lamina propria of the
intestinal villi or in small groups at the base of the villi (Fig. 2AeC),
but hardly ever in the epithelial layer. In embryonic (Fig. 2A) or
neonatal samples (d1, d4, data not shown), CATH-2 expressing cells
were also found in the serosa. In the lymphoid tissue of the cecal
tonsils, CATH-2 expressing heterophils were quite numerous
around the developing lymphoid follicles (Fig. 2D).
In the bursa and spleen, CATH-2 expressing cells were very
numerous during embryonic and neonatal (d1) timepoints. Clusters
of these cells ﬁlled the bursal mesenchyme between the developing
lymphoid follicles (Fig. 3A) and the red pulp of the spleen (Fig. 3C).
From 1 week posthatch onwards, very few CATH-2 expressing cells
remained in the bursa and were seen only at the edge of some
follicles in small groups, but never in the follicular medulla (Fig. 3B).
In the spleen, CATH-2 expressing heterophils remained present in
relatively large numbers until the last timepoint (d28) scattered
throughout the red pulp (Fig. 3D). Throughout embryonic devel-
opment, clusters of CATH-2 expressing heterophils similar to those
observed in the bursa and spleen were also seen in the yolk,t seen in rare cells at ed14 (A), expressing cell numbers grew much more numerous in
, C and cecum, D). Typical shapes of AvBD9 expressing cells were spindle shaped in villi
Fig. 5. Identity of the AvBD9 expressing cells in the intestine. A-D: Sequential stain with AvBD9 antibody (A,C) and HE (B,D) of jejunum (A,B) and cecum (C,D). Serial stain of ileum
with AvBD9 antibody (E) and argentafﬁn Fontana-Masson silver stain (F). Arrows indicate overlap between AvBD9 expressing cells and silver stain.
Fig. 6. Identity of the AvBD9 expressing cells in the intestine. Serial intestinal sections stained with AvBD9 (A,C,E) and enteroendocrine products 5-HT (B, cecum), GLP-1 (D,
jejunum) and GIP (F, jejunum). Arrows denote examples of overlapping cells, asterisks indicate non-overlapping cells.
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In the embryonic lung at ed12 and ed14, only few dispersed
heterophils were found (data not shown). At ed16, clusters of
CATH-2 expressing cells were seen surrounding the blood vessels
(Fig. 3E). At all posthatch timepoints, CATH-2 expressing hetero-
phils were observed throughout the entire lung parenchyme as
single cells or in small groups (Fig. 3F).
In the skin at all studied timepoints, small numbers of CATH-2
expressing cells were seen scattered throughout the dermis as
single cells, but in embryonic and neonatal (d1, d4) samples the
cells also occurred as small clusters (Fig. 3H). Only from ed14 to
ed20 heterophils could also be observed in the pulp of the feather
follicles (Fig. 3G).
The developmental stage of heterophils (based on descriptions
in (Lucas and Jamroz, 1961)) in spleen, bursa and cecum was
deﬁned by assessment of the morphology of heterophils in Giemsa
stained sections at ed18 and d28. At ed18, the majority of hetero-
phils seen in spleen, bursa and cecumwere identiﬁed as immature
cells, mainly meso- andmetamyelocytes with round granules and a
large nucleus (Fig. S1AeC). A small number of promyelocytes with
pale granules were also present in the spleen, but blast forms were
not observed. Mature heterophils, characterized by rod-shaped
granules and a bi-lobed nucleus were only occasionally seen. Four
weeks posthatch, most of the heterophils in the spleen and the
cecum were compact mature cells, though a minority of meso-
myelocytes with round granules was still present (Fig. S1B,F). In
contrast, in the bursa at d28, among the small number of hetero-
phils present, the majority were of an immature phenotype
(Fig. S1D).
3.2. Localization and identity of AvBD9 expressing cells
AvBD9 expression was mainly found in the intestine. Cells
expressing AvBD9 were observed in all examined parts of theFig. 7. AvBD9 expression in cecal tonsils, lung and spleen. A-B: serial stain of cecal tonsil
expression in spleen (C) and lung (D) at d28.intestine, from the duodenum to the colon. Rare AvBD9 expressing
cells were ﬁrst seen at ed14, numerous stained cells were observed
from ed16 onwards (Fig. 4AeB). Single AvBD9 expressing cells were
spread throughout the villi (more frequently in the lower half) and
crypts (Fig. 4C,D), always located basally in the epithelial layer. Two
different cell morphologies of AvBD9 expressing cells were
observed. Bottle-shaped or elongated cells were seen in the villi of
the small intestine, oftenwith a slender apical process reaching the
luminal surface (Fig. 4E). Round or pyramid shaped AvBD9
expressing cells were found in the cecum and in crypts throughout
the intestine (Fig. 4F). AvBD9 staining was cytoplasmic with a
granular pattern and a clearly non-staining nucleus.
By staining intestinal sections sequentially with HE followed by
AvBD9 antibody, we assessed the morphology of AvBD9 expressing
cells (Fig. 5AeD). In HE stained sections, AvBD9 expressing cells
showed a basal concentration of bright pink staining granules
(Fig. 5B,D). These morphological characteristics gave reason to
believe that AvBD9 expressing cells were enteroendocrine cells
(EECs). To conﬁrm this, intestinal sections were stained with the
argentafﬁn Fontana-Masson silver stain, traditionally used to detect
EECs. When comparing serial sections stained with Fontana-
Masson and AvBD9, silver-stained cells were shown to overlap
with AvBD9 expressing cells in all parts of the intestine (Fig. 5E,F).
To further characterize the identity of this AvBD9 expressing cell
type, serial intestinal sections were stained pairwise with AvBD9
antibody and antibodies against three EEC products: serotonin (5-
HT), gastric-inhibitory peptide (GIP), and glucagon-like peptide
(GLP-1). AvBD9 expressing cells overlapped strongly with cells
expressing 5-HT in all studied parts of the intestine, though cells
expressing only 5-HT and no AvBD9 were also observed (Fig. 6A,B).
AvBD9 expression displayed only partial overlap with GLP-1 and
GIP expressing cells. Overlap of AvBD9 and GLP-1 expressing cells
was most pronounced in the cecum, with only little overlap seen in
the small intestine (as shown for jejunum in Fig. 6C,D). In the casewith AvBD9 antibody (A) and GLP-1 antibody (B). Representative examples of AvBD9
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displaying aweak GIP signal, while cells with a strong GIP signal did
not overlap with AvBD9 expressing cells (Fig. 6E,F).
In addition to EECs, intestinal AvBD9 expressionwas also seen in
the lymphoid tissue of the cecal tonsils. AvBD9 expressing cells
here were mostly found at the edges of the lymphoid follicles in
small clusters (Fig. 7A). Morphologically, these cells appeared large
and round with much cytoplasm and occasionally vacuoles. These
AvBD9 expressing cells also demonstrated faint Fontana-Masson
staining (data not shown) and overlapped with GIP (data not
shown) and GLP-1 stain (Fig. 7AeB).
Outside of the intestine, AvBD9 expression was only found in
rare instances in the spleen and lungs of 3 and 4 week old chickens
as single expressing cells or small clusters (Fig. 7C,D). In appear-
ance, these were small round cells. No clearly deﬁned anatomical
location for this AvBD9 expressionwas apparent. AvBD9 expressing
cells were not found in the kidney, trachea, skin, bursa or in blood
smears.
3.3. Quantitative expression of CATH-2 during development
The developmental expression pattern of CATH-2 was differentFig. 8. Quantitative expression of CATH-2 in the gastro-intestinal tract during developme
Expression is presented as percentage stained area, as an average of 10 ﬁelds (400x magn
statistically signiﬁcant differences between developmental stages (p < 0.05). Data for lung, sp
Kruskal-Wallis test.between the studied organs. In gastro-intestinal tissues, numbers
of CATH-2 expressing heterophils were low in general, but a pattern
of higher expression in embryos and neonatal animals compared to
older animals was seen in the small intestine (Fig. 8AeC). In the
duodenum, expression at d7 was lower compared to all previous
measured days (Fig. 8A). In the ileum and jejunum, expression at d7
and 14 respectively was signiﬁcantly lower compared to d1
(Fig. 8B,C). In cecum and tonsils, no signiﬁcant differences in CATH-
2 expression were seen during development (Fig. 8D,E).
In the spleen and bursa, CATH-2 expression was highest at ed18
(Fig. 9A,B). In the spleen, CATH-2 expressing heterophils covered
more than 20% of the measured area at this timepoint. As devel-
opment proceeds, a steady decline in expression was seen until d4
in the bursa and d7 in the spleen. After this, CATH-2 expression
remained relatively low and no further changes were seen.
In the lung, expression did not exceed 1% of the measured area
(Fig. 9C). CATH-2 expression was biphasic with an increase from
ed16 to d1, after which a decrease was seen until d14. Expression at
d1 is the highest and signiﬁcantly higher than expression at ed16,
d4, 7 and 14. In the skin, CATH-2 expression was low at all
measured timepoints and no signiﬁcant differences in expression
were seen (Fig. 9D).nt: duodenum (A), jejunum (B), ileum (C), cecum (D) and cecal tonsil (E) (n ¼ 3e5).
iﬁcation, 0.09 mm2) per sample. Different characters at the top of the graphs indicate
leen and skin were analyzed by one-way ANOVA, data for bursa were analyzed using a
Fig. 9. Quantitative expression of CATH-2 in bursa (A), spleen (B), lung (C) and skin (D) during development (n ¼ 3e5). Expression is presented as percentage stained area, as an
average of 10 ﬁelds (400x magniﬁcation, 0.09 mm2) per sample. Different characters at the top of the graphs indicate statistically signiﬁcant differences between developmental
stages (p < 0.05). Data for duodenum and cecum were analyzed by one-way ANOVA, data for jejunum, ileum and tonsil were analyzed using a Kruskal-Wallis test.
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AvBD9 expression was measured quantitatively only in the in-
testine. In general, about 5-15 AvBD9 expressing cells were seen per
ﬁeld (Fig. S2). Very little difference in expression was seen over the
course of development, both in percentage of measured area and
cell numbers. In the jejunum, the percentage expression of
measured area was signiﬁcantly lower at d14 compared to ed20,
while in the duodenum and ileum, an apparent lower expression
was seen at ed18 compared to later timepoints (Fig. 10).4. Discussion
In this work, we report the expression patterns of two chicken
HDPs: CATH-2 and AvBD9, during embryonic and posthatch
development. Our group previously reported broad antimicrobial
activity for both CATH-2 and AvBD9, and for CATH-2 immuno-
modulatory activities were also described, in line with the
mammalian counterparts of these peptides (Coorens et al., 2015;
van Dijk et al., 2007; van Dijk et al., 2009a; van Dijk et al.,
2009b). In the present work, our earlier ﬁndings on CATH-2 local-
ization (van Dijk et al., 2009a) are extended by examining a large
set of tissues including intestinal, respiratory and lymphoid organs
of numerous developmental stages, only ﬁnding CATH-2 expressed
in heterophils, the avian counterpart of the mammalian neutrophil.
Cathelicidins of multiple animal species were ﬁrst isolated from
neutrophils (Cowland et al., 1995; Larrick et al., 1991), but were
later found to be expressed in multiple cell types. In addition to
neutrophils, the human cathelicidin LL-37 is expressed amongst
others in monocytes, lymphocytes and epithelia of the skin and gut
(Agerberth et al., 2000; Dorschner et al., 2003; Hase et al., 2002). A
similar expression proﬁle has been reported for the mouse cath-
elicidin CRAMP, and the porcine cathelicidin PR-39 was shown to
be expressed in multiple cell types of the lung (Hennig-Pauka et al.,2012). To our knowledge, a cathelicidin with exclusive protein
expression in granulocytes has not been described to date. CATH-2
mRNA expression has a very broad tissue distribution, which cor-
responds well with expression in the ubiquitous heterophils (van
Dijk et al., 2005). There are indications however that mRNA
expression of CATH-2 may extend beyond heterophils (Sunkara
et al., 2011). The chickens used in the present work were healthy
animals, so the question remains whether CATH-2 expression can
be induced in other cell types during infections. In young broilers
infected with Salmonella enteritidis or Campylobacter jejuni CATH-2
expression in cecum and jejunumwas only seen in heterophils (van
Dijk et al., 2009a; van Dijk et al., 2012). If this exclusive heterophil
expression remains true in other infectious states, CATH-2 may be
considered as a heterophil marker, which could be very useful for
infection and immune related research in poultry.
Based on CATH-2 staining, we were able to elucidate develop-
mental distribution patterns of heterophils in multiple organs. In
many of the organs studied a decrease in CATH-2 expressing het-
erophil numbers is seen shortly after hatch, most strongly in the
bursa and the spleen. Bursa and spleen, but also kidney, pancreas
and thymus are known sites of extramedullary hematopoiesis in
the chicken embryo (Lucas and Jamroz, 1961; Romanoff, 1960;
Shiojiri and Takahashi, 1991) and small-scale granulopoiesis in
the intestine has also been reported (Bar-Shira and Friedman,
2006). This corresponds well with the presence of developing
heterophils in bursa, spleen and cecum in embryonic samples.
Posthatch, hematopoiesis in these organs largely seizes and is taken
over by the bone marrow. In chicks younger than 1 week of age,
very high heterophil numbers are seen in the blood, believed to be
caused by the efﬂux of heterophils from the spleen (Lucas and
Jamroz, 1961). These increased blood heterophil numbers may
compensate for the relative immaturity of the adaptive immune
system in this period. Interestingly, while in the spleen and cecum
at day 28 we saw mostly mature heterophils, the bursa still
Fig. 10. Quantitative expression of AvBD9 in the gastro-intestinal tract during development (n ¼ 3e5): duodenum (A), jejunum (B), ileum (C), cecum (D) and tonsil (E). Expression is
presented as percentage stained area, as an average of 10 ﬁelds (400x magniﬁcation, 0.09 mm2) per sample. Different characters at the top of the graphs indicate statistically
signiﬁcant differences between developmental stages (p < 0.05). Data were analyzed by one-way ANOVA.
T. Cuperus et al. / Developmental and Comparative Immunology 61 (2016) 48e59 57contained developing cells at this timepoint. The presence of
granulocytes around lymphoid follicles was previously described
for the bursa (Aita andMinella, 1983) and was also seen in the cecal
tonsils in our study. Heterophils might thus be involved in regu-
lating B and Tcell functions as is known formammalian neutrophils
(Mocsai, 2013). A biphasic expression patternwas found for CATH-2
expression in the lung. Possibly, the high CATH-2 expression at day
1 posthatch is due to heterophil recruitment resulting from the ﬁrst
exposure of this organ to the external environment upon hatching.
The CATH-2 developmental expression reported here deviates from
a previously reported analysis based onmRNA (Achanta et al., 2012)
where an increase in the CATH-2 mRNA expression in the bursa,
cecum and cecal tonsils was seen in the period from 2 to 28 days
posthatch. As suggested above, mRNA expression of CATH-2 might
be broader than the heterophil speciﬁc protein expression and
therefore show a different developmental pattern.
The majority of AvBD9 expressing cells in the intestine could be
identiﬁed as EECs based on cell morphology, overlap with argen-
tafﬁn silver stain and co-localizationwith EEC products. Among the
approximately 12 EEC cell types are enterochromafﬁn cells
expressing serotonin (Furness et al., 2013; Rindi et al., 2004), which
were found to be strongly co-localizing with AvBD9. As entero-
chromafﬁn cells are the most widely distributed of the EEC types,this co-localization corresponds well with the wide distribution of
AvBD9 expressing cells in all parts of the chicken intestine. Some
AvBD9 expressionwas also found in EECs expressing GIP and GLP-1,
in mammals called K and L cells, respectively. Previously, mRNA
expression of AvBD9 was reported to be low in the gastro-intestinal
tract and high in the liver, kidney and bursa (van Dijk et al., 2007;
Xiao et al., 2004).
Here we report for the ﬁrst time in vivo protein expression of a
defensin in EECs. Previously, expression of murine b-defensin 2 was
reported in the EEC cell line STC-1, but expression was not
conﬁrmed in mouse tissues (Palazzo et al., 2007). EECs are well
described for their role in regulation of digestion, intestinal motility
and appetite, but a growing number of publications also ascribes to
them a role in host defense. EECs were reported to express TLRs and
respond to TLR ligands by secretion of both hormonal products and
innate immune molecules (Bogunovic et al., 2007; Palazzo et al.,
2007; Selleri et al., 2008). In addition, roles in defense have been
described for some EEC derived hormones. For example, GLP-2 and
cholecystokinin were shown to have anti-inﬂammatory effects in
in vivo models and somatostatin was able to inhibit IL-1b and IL-8
secretion from intestinal epithelial cells (Chowers et al., 2000;
Meng et al., 2002; Sigalet et al., 2007). In chickens, both somato-
statin and 5-HT were shown to inﬂuence immune responses to
T. Cuperus et al. / Developmental and Comparative Immunology 61 (2016) 48e5958infectious challenges (Donato et al., 2015; Yang et al., 2007).
Interestingly, deletion of the GLP-2 receptor in mice reduced Pan-
eth cell a-defensin expression, showing another link between in-
testinal defensin expression and EECs (Lee et al., 2012).
EECs secrete their products basolaterally into the lamina prop-
ria, enabling interactions between these secreted compounds with
residing immune cells. Human and murine enteric defensins have
been shown to be chemotactic, to induce dendritic cell differenti-
ation and maturation and to increase T cell cytokine production
(Meisch et al., 2013; Presicce et al., 2009; Rohrl et al., 2010; Scudiero
et al., 2010; Yang et al., 1999). It is interesting to speculate that a
similar role may exist for AvBD9 released by chicken EECs.
In contrast to CATH-2, very little difference in AvBD9 expression
was seen over the course of development from ed18 onwards.
Though quantitative analysis was not possible before ed18, quali-
tatively a large increase in expression was seen after the ﬁrst
observation of AvBD9 expressing cells at ed14. Expression of many
EEC products is also ﬁrst seen around ed14, indicating functional
maturation of EECs at this timepoint (Rawdon and Andrew, 1999).
Previously, gene expression of avian intestinal defensins (AvBD1, -2,
-4 and -6) was measured in the gut of developing chickens,
showing clear developmental regulationwith a decrease in the ﬁrst
week posthatch followed by an increase in the second week (Bar-
Shira and Friedman, 2006; Crhanova et al., 2011). The expression
of human b-defensin 1 is constitutive and already present in fetal
intestines (O'Neil et al., 1999), it appears from our ﬁndings this is
also true for AvBD9.
Data about the expression of AvBD9 in infected animals are rare,
though infection with Salmonella enteritidis in geese increased
AvBD9 mRNA expression in cecal tonsils, but not in small intestine
(Ma et al., 2012). Even in the healthy chickens in our study, AvBD9
expression is not limited to EECs, as we also report expression in
the lung, the spleen and the lymphoid tissue of the cecal tonsils.
The AvBD9 mRNA expression has an even broader tissue distribu-
tion (Lynn et al., 2004; van Dijk et al., 2007; Xiao et al., 2004),
suggesting that, even though protein expression was only found in
a few organs in this study, expressionmight verywell be induced in
more organs and cell types under certain conditions.
In short, this study describes protein expression of two chicken
host defense peptides during embryonic and posthatch develop-
ment and reports two very distinct patterns of expression. Both
peptides are constitutively expressed in speciﬁc cells, CATH-2 in
heterophils and AvBD9 in EECs, cell types strategically located to
quickly mount a response to infectious stimuli. CATH-2 and AvBD9
thus appear to be essential in host defense in both embryos and
neonates, as well as in older animals.
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